ReadWrite6d
X starts labeling parody accounts in bid to add transparency
X will start adding parody labels to accounts and posts as the company tries to add some form of transparency to the platform ...
Hosted on MSN2d
Mediar Therapeutics signs licensing deal with Eli Lilly for IPF treatment
Mediar Therapeutics has entered a global licensing agreement with Eli Lilly and Company to progress the human immunoglobulin ...
Eli Lilly Q4 miss brings buying opportunity, says JPMorgan
JPMorgan analyst Chris Schott says Eli Lilly’s Q4 miss represents a buying opportunity as the company is positioned for strong growth in 2025. The company’s 2025 sales guidanc ...
Hosted on MSN29d
Eli Lilly’s Mounjaro Won’t Have Separate Sleep Apnea Label in EU
(Bloomberg) -- Eli Lilly & Co.’s weight-loss and diabetes drug Mounjaro won’t be reclassified as a sleep apnea treatment in Europe, with regulators saying Friday that use of the drug is ...
FiercePharma9d
‘Ozempic’s biggest night’: GLP-1s back in Hollywood spotlight at 2025 Golden Globes
Comedian Nikki Glaser, host of the 2025 Golden Globe Awards ceremony, dove right in at the start of her opening monologue: ...
Eli Lilly & Co.: Positive Long-Term Outlook Despite Recent Setbacks – Buy Rating Affirmed
Analyst Mohit Bansal from Wells Fargo maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) and keeping the price target at ...